Abstract

We evaluated spine bone mineral density (BMD) in Brazilian children with juvenile systemic lupus erythematosus (JSLE) in order to detect potential predictors of reduction in bone mass. A cross-sectional study of BMD at the lumbar spine level (L2-L4) was conducted on 16 female JSLE patients aged 6-17 years. Thirty-two age-matched healthy girls were used as control. BMD at the lumbar spine was measured by dual-energy X-ray absorptiometry. Weight, height and pubertal Tanner stage were determined in patients and controls. Disease duration, mean daily steroid doses, mean cumulative steroid doses and JSLE activity measured by the systemic lupus erythematosus disease activity index (SLEDAI) were determined for all JSLE patients based on their medical charts. All parameters were used as potential determinant factors for bone loss. Lumbar BMD tended to be lower in the JSLE patients, however, this difference was not statistically significant (P = 0.10). No significant correlation was observed in JSLE girls between BMD and age, height, Tanner stage, disease duration, corticosteroid use or disease activity. We found a weak correlation between BMD and weight (r = 0.672). In the JSLE group we found no significant parameters to correlate with reduced bone mass. Disease activity and mean cumulative steroid doses were not related to BMD values. We did not observe reduced bone mass in female JSLE.

Highlights

  • Osteoporosis is a major public health problem affecting postmenopausal women and older persons in general

  • Steroids are a mainstay of drug therapy in systemic lupus erythematosus (SLE) and are a well-recognized cause of osteoporosis in rheumatoid arthritis and other conditions such as asthma [18,19,20,21]

  • Our results did not demonstrate that children with juvenile systemic lupus erythematosus (JSLE) present a reduced bone mass at the lumbar spine level compared to healthy children

Read more

Summary

Introduction

Osteoporosis is a major public health problem affecting postmenopausal women and older persons in general. Due to improvements in instrumentation we can detect this condition in children. Significant osteopenia has been detected in children with diseases such as juvenile dermatomyositis, juvenile rheumatoid arthritis and juvenile systemic lupus erythematosus (JSLE) [1,2,3,4,5]. There is no consensus about the extent of the impact of these factors on bone mineral density (BMD) in children with rheumatic diseases, it is important to understand their implications in order to plan further strategies to prevent and treat bone disease in these children. The objective of the present study was to assess BMD in

Objectives
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.